Projects

IrsiCaixa is involved in a hundred national and international research projects active each year, funded by both public and private entities.

Keywords

Research group

Researcher

From date

To date

Vaccine against Covid-19: pilot project of plasma-derived exosomes from patients (ExoCoVac)

Project status

Ongoing

Start/End

2020

/

2021

Principal investigator

Javier Martínez-Picado

Participating entities

IrsiCaixa AIDS Research Institute, Barcelona Institute for Global Health (ISGlobal)

Strategic lines

Cancer

Emerging infectious diseases

Financing entity

ISGlobal, YoMeCorono (crowdfunding)
Novel therapeutic agents to block interactions between enveloped viruses and myeloid cells: combating the settlement of infections (BLOCKER-PRO)

Project status

Ongoing

Start/End

2017

/

2019

Principal investigator

Javier Martínez-Picado

Nuria Izquierdo Useros

Participating entities

IrsiCaixa AIDS Research Institute

Financing entity

Spanish Ministry of Economy and Competitiveness, Secretariat of state for research, development and innovation; ref. SAF2016-80033-R
COVID Human Genetic Effort

Project status

Ongoing

Start/End

2020

/

2021

Principal investigator

Javier Martínez-Picado

Participating entities

IrsiCaixa AIDS Research Institute

Strategic lines

Cancer

Emerging infectious diseases

Financing entity

YoMeCorono (crowdfunding)
New genetic engineering tools for the treatment of AIDS "STOP-AIDS"

Project status

Ongoing

Start/End

2016

/

2019

Principal investigator

Javier Martínez-Picado

Participating entities

IrsiCaixa AIDS Research Institute and 3 other Spanish centers.

Financing entity

Spanish Ministry of Economy and Competitiveness, Secretariat of state for research, development and innovation; Retos-Colaboración RTC-2016-5324-1
Nuevas estrategias terapéuticas basadas en inhibidores de tirosina kinasas para la eliminación del reservorio latente del VIH-1 (TKICure)

Project status

Ongoing

Start/End

2020

/

2023

Principal investigator

Javier Martínez-Picado

Participating entities

IrsiCaixa AIDS Research Institute, Instituto de Salud Carlos III

Strategic lines

Therapies and vaccines

Financing entity

Spanish Ministry of Science and Innovation
DURVAST: A phase II exploratory study of durvalumab (MEDI4736) in HIV-1 patients with advanced solid tumors

Project status

Ongoing

Start/End

2017

/

2019

Principal investigator

Javier Martínez-Picado

Participating entities

Spanish Lung Cancer Cooperative Group & IrsiCaixa AIDS Research Institute.

Financing entity

AstraZeneca
Non-invasive viral reservoir characterization in Lymph Nodes through Fine Needle Biopsies in patients with distinct HIV progression profiles

Project status

Ongoing

Start/End

2017

/

2019

Principal investigator

Javier Martínez-Picado

Participating entities

IrsiCaixa AIDS Research Institute

Financing entity

Gilead Sciences
Glicoingeniería de nanovehículos para eliminar los reservorios virales; saf2017-91767-exp

Project status

Ongoing

Start/End

Principal investigator

Nuria Izquierdo Useros

Participating entities

Irsicaixa, ICN2, UPV-CSIC

Financing entity

MINECO